Luo, Z., Zhang, X., Zhao, T., Xu, M., Wang, Q., Wang, Y., Zhou, L., Hu, S., Xu, Q., Hu, X., Liu, X. (2025). PD-1 blockade in combination with bevacizumab and nab-paclitaxel for second-line treatment in cancer of unknown primary (Fudan CUP-002): A prospective, single-arm phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2529